1273714

SPI Pharma, SAS — FEI 3003755498

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Septemes Les Vallons (France)

Additional Details

Mutual Recognition Agreement (MRA)